J
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
J. Gandy's research interests include drug delivery systems, particularly liposome formulations for tumor-targeted applications in radiation therapy. Recent work also addresses vaccine uptake and seroprevalence of SARS-CoV-2 among college students in Arkansas, investigating mitigation behaviors and longitudinal antibody levels. Gandy leads a research group and has a designation as a highly cited researcher, with 76 total publications and 1,642 citations, holding an h-index of 20. Collaborations include work with researchers at the University of Arkansas at Little Rock and within the University of Arkansas for Medical Sciences.
Metrics
- h-index: 20
- Publications: 76
- Citations: 1,650
Selected Publications
-
COVID-19 Vaccine Uptake Among Students in Public Institutions of Higher Education in Arkansas in 2021 (2023)
-
A longitudinal study of SARS-CoV-2 antibody seroprevalence and mitigation behaviors among college students at an Arkansas University (2023)
-
Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy (2022)
-
Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy (2022)
Collaboration Network
Top Collaborators
Amanda J. Stolarz
University of Arkansas for Medical Sciences
2 shared publications
In database
- Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy
- Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy
Bijay P. Chhetri
2 shared publications
In database
- Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy
- Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy
Michael J. Borrelli
University of Arkansas for Medical Sciences (US)
2 shared publications
- Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy
- Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy
Samir V. Jenkins
University of Arkansas for Medical Sciences
2 shared publications
In database
- Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy
- Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy
Azemat Jamshidi‐Parsian
University of Arkansas for Medical Sciences
2 shared publications
In database
- Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy
- Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy
Joshua H. Phillips
2 shared publications
- Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy
- Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy
Daniel Fologea
Boise State University (US)
2 shared publications
- Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy
- Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy
Robert J. Griffin
University of Arkansas for Medical Sciences (US)
2 shared publications
- Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy
- Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy
Benjamin C. Amick
Winthrop Rockefeller Foundation (US)
2 shared publications
- A longitudinal study of SARS-CoV-2 antibody seroprevalence and mitigation behaviors among college students at an Arkansas University
- COVID-19 Vaccine Uptake Among Students in Public Institutions of Higher Education in Arkansas in 2021
Jaimi L. Allen
University of Arkansas for Medical Sciences (US)
1 shared publication
- A longitudinal study of SARS-CoV-2 antibody seroprevalence and mitigation behaviors among college students at an Arkansas University
Mark L. Williams
University of Arkansas for Medical Sciences
1 shared publication
In database
- A longitudinal study of SARS-CoV-2 antibody seroprevalence and mitigation behaviors among college students at an Arkansas University
Joshua L. Kennedy
Arkansas Children's Hospital
1 shared publication
In database
- A longitudinal study of SARS-CoV-2 antibody seroprevalence and mitigation behaviors among college students at an Arkansas University
Karl W. Boehme
Inflammatory Response Research (United States) (US)
1 shared publication
- A longitudinal study of SARS-CoV-2 antibody seroprevalence and mitigation behaviors among college students at an Arkansas University
J. Craig Forrest
University of Arkansas for Medical Sciences
1 shared publication
In database
- A longitudinal study of SARS-CoV-2 antibody seroprevalence and mitigation behaviors among college students at an Arkansas University
Brian A. Primack
Arkansas Department of Health (US)
1 shared publication
- A longitudinal study of SARS-CoV-2 antibody seroprevalence and mitigation behaviors among college students at an Arkansas University
Similar Researchers
Based on overlapping research topics
Lawrence E. Cornett
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Vaccine Coverage and Hesitancy
Health Sciences Research and Education
M. Kathryn Allison
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Vaccine Coverage and Hesitancy
Health Sciences Research and Education
Luke H. Lefler
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Vaccine Coverage and Hesitancy
Health Sciences Research and Education
Fuad Haydar
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Vaccine Coverage and Hesitancy
Health Sciences Research and Education
Tabasum Imran
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Vaccine Coverage and Hesitancy
Health Sciences Research and Education
T. Scott Warmack
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Vaccine Coverage and Hesitancy
Health Sciences Research and Education